Shares of USA-based NextCure slumped 26% to $0.50 on Monday, after the company announced a strategic partnership with ...

Israel’s Teva Pharmaceutical Industries and Shanghai Fosun Pharmaceutical have entered a strategic partnership for the ...

Cambridge, UK-based Maxion Therapeutics today announced the appointment of Dr Stefan Härtle as chief development officer, ...

TTAM Research Institute, a nonprofit public benefit corporation based in California and led by 23andMe co-founder and former ...

Swiss pharma giant Roche announced today its decision to proceed with Phase III development of prasinezumab, an ...

A second case of acute liver failure (ALF) resulting in the death has been reported in a young recipient of Elevidys ...

French drug developer Averoa today announced that the European Commission (EC) has granted marketing authorization for ...

Boston, USA-based biotech Solu Therapeutics today announced the appointment of Enda Moran as chief operating officer (COO).

Scientists at The Institute of Cancer Research, London, claim to have discovered what may cause some treatments to stop working in people living with bowel cancer.

Supernus Pharmaceuticals (Nasdaq: SUPN) is to buy Sage Therapeutics (Nasdaq: SAGE) for total consideration of around $795 million. Shares in Sage shot up by 35% amid the news by midday Monday, while ...